Trials / Sponsors / Mapi Pharma Ltd.
Mapi Pharma Ltd.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Ca Major Depressive Disorder (MDD), Bipolar 1 Disorder, Schizophrenia | Phase 1 / Phase 2 | 2025-08-01 |
| Completed | A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2019-09-19 |
| Active Not Recruiting | Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS Primary Progressive Multiple Sclerosis | Phase 2 | 2017-12-11 |
| Completed | Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With Multiple Sclerosis | Phase 1 / Phase 2 | 2014-10-01 |